Durata Therapeutics is a clinical development stage pharmaceutical company.
Business Model:
Revenue: $10.1M
Employees: 51-200
Durata Therapeutics was acquired by
Actavis.
The acquisition happend on 2014-10-06.
Details of the transaction were not public
Address: 200 S Wacker Dr
City: Chicago
State: IL
Zip: 60606
Country: US
Durata Therapeutics is a clinical development stage pharmaceutical company.
Contact Phone:
+13122197000
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/19/2012
Ticker Symbol:
DRTX
IPO Price:
$9/share
Amount Raised:
$68M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2012 | IPO | $67.5M |
|
11/2013 | Post-IPO Equity | $0 |
PDL Biopharma PDL Biopharma |
11/2013 | Post-IPO Equity | 1 | $70M |
PDL Biopharma PDL Biopharma |
---|
Announced Date | Name | Price |
---|---|---|
12/2009 | Vicuron Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|